Package 68001-480-35

{"route": ["INTRAVENOUS"], "spl_id": "30b09e30-01bd-efc4-e063-6394a90aabc3", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324"], "spl_set_id": ["b66dbd6d-6ccb-ce9d-e053-2995a90a4c3c"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480-22)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-480-22", "marketing_start_date": "20201214"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480-35)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-480-35", "marketing_start_date": "20201214"}], "brand_name": "Irinotecan hydrochloide", "product_id": "68001-480_30b09e30-01bd-efc4-e063-6394a90aabc3", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "68001-480", "generic_name": "Irinotecan hydrochloide", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan hydrochloide", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA212993", "marketing_category": "ANDA", "marketing_start_date": "20201214", "listing_expiration_date": "20261231"}